MEDIWOUND LTD (MDWD) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:MDWD • IL0011316309

17.95 USD
+0.16 (+0.9%)
At close: Feb 9, 2026
17.95 USD
0 (0%)
After Hours: 2/9/2026, 8:14:39 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to MDWD. MDWD was compared to 191 industry peers in the Pharmaceuticals industry. MDWD may be in some trouble as it scores bad on both profitability and health. MDWD is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • MDWD had negative earnings in the past year.
  • In the past year MDWD has reported a negative cash flow from operations.
  • In the past 5 years MDWD always reported negative net income.
  • MDWD had a negative operating cash flow in each of the past 5 years.
MDWD Yearly Net Income VS EBIT VS OCF VS FCFMDWD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

  • MDWD has a Return On Assets (-21.82%) which is comparable to the rest of the industry.
  • The Return On Equity of MDWD (-41.08%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -21.82%
ROE -41.08%
ROIC N/A
ROA(3y)-30.14%
ROA(5y)-37.73%
ROE(3y)-99.31%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MDWD Yearly ROA, ROE, ROICMDWD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 -200

1.3 Margins

  • MDWD has a Gross Margin of 18.53%. This is comparable to the rest of the industry: MDWD outperforms 52.36% of its industry peers.
  • In the last couple of years the Gross Margin of MDWD has declined.
  • The Profit Margin and Operating Margin are not available for MDWD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-29.33%
GM growth 5Y-26.97%
MDWD Yearly Profit, Operating, Gross MarginsMDWD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • MDWD does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for MDWD has been increased compared to 1 year ago.
  • Compared to 5 years ago, MDWD has more shares outstanding
  • Compared to 1 year ago, MDWD has an improved debt to assets ratio.
MDWD Yearly Shares OutstandingMDWD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
MDWD Yearly Total Debt VS Total AssetsMDWD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • A Debt/Equity ratio of 0.16 indicates that MDWD is not too dependend on debt financing.
  • With a Debt to Equity ratio value of 0.16, MDWD perfoms like the industry average, outperforming 47.12% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC8.59%
MDWD Yearly LT Debt VS Equity VS FCFMDWD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

  • MDWD has a Current Ratio of 2.65. This indicates that MDWD is financially healthy and has no problem in meeting its short term obligations.
  • With a Current ratio value of 2.65, MDWD perfoms like the industry average, outperforming 47.12% of the companies in the same industry.
  • A Quick Ratio of 2.48 indicates that MDWD has no problem at all paying its short term obligations.
  • With a Quick ratio value of 2.48, MDWD perfoms like the industry average, outperforming 50.26% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.65
Quick Ratio 2.48
MDWD Yearly Current Assets VS Current LiabilitesMDWD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • MDWD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 34.48%, which is quite impressive.
  • Looking at the last year, MDWD shows a small growth in Revenue. The Revenue has grown by 6.15% in the last year.
  • The Revenue has been decreasing by -8.65% on average over the past years.
EPS 1Y (TTM)34.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.51%
Revenue 1Y (TTM)6.15%
Revenue growth 3Y-5.23%
Revenue growth 5Y-8.65%
Sales Q2Q%24.66%

3.2 Future

  • Based on estimates for the next years, MDWD will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.21% on average per year.
  • MDWD is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 42.10% yearly.
EPS Next Y28.9%
EPS Next 2Y9.39%
EPS Next 3Y8.34%
EPS Next 5Y17.21%
Revenue Next Year5.29%
Revenue Next 2Y14.07%
Revenue Next 3Y18.05%
Revenue Next 5Y42.1%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MDWD Yearly Revenue VS EstimatesMDWD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100M 200M 300M
MDWD Yearly EPS VS EstimatesMDWD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 5 -5

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for MDWD. In the last year negative earnings were reported.
  • Also next year MDWD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MDWD Price Earnings VS Forward Price EarningsMDWD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MDWD Per share dataMDWD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y9.39%
EPS Next 3Y8.34%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • MDWD does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MEDIWOUND LTD

NASDAQ:MDWD (2/9/2026, 8:14:39 PM)

After market: 17.95 0 (0%)

17.95

+0.16 (+0.9%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-20
Earnings (Next)03-17
Inst Owners46.82%
Inst Owner Change1.15%
Ins Owners1.42%
Ins Owner ChangeN/A
Market Cap230.12M
Revenue(TTM)20.93M
Net Income(TTM)-20.60M
Analysts83.33
Price Target32.13 (79%)
Short Float %10.61%
Short Ratio9.72
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-19.96%
Min EPS beat(2)-110.94%
Max EPS beat(2)71.01%
EPS beat(4)3
Avg EPS beat(4)22.9%
Min EPS beat(4)-110.94%
Max EPS beat(4)89.63%
EPS beat(8)4
Avg EPS beat(8)-27.36%
EPS beat(12)6
Avg EPS beat(12)-15.44%
EPS beat(16)7
Avg EPS beat(16)-15.08%
Revenue beat(2)0
Avg Revenue beat(2)-10.67%
Min Revenue beat(2)-19.91%
Max Revenue beat(2)-1.43%
Revenue beat(4)0
Avg Revenue beat(4)-11.79%
Min Revenue beat(4)-25.41%
Max Revenue beat(4)-0.39%
Revenue beat(8)1
Avg Revenue beat(8)-9.43%
Revenue beat(12)3
Avg Revenue beat(12)-1.65%
Revenue beat(16)5
Avg Revenue beat(16)-0.71%
PT rev (1m)0%
PT rev (3m)2.72%
EPS NQ rev (1m)-6.46%
EPS NQ rev (3m)25.54%
EPS NY rev (1m)-1.99%
EPS NY rev (3m)22.23%
Revenue NQ rev (1m)-22.45%
Revenue NQ rev (3m)-22.27%
Revenue NY rev (1m)-7.7%
Revenue NY rev (3m)-11.88%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 10.99
P/FCF N/A
P/OCF N/A
P/B 4.59
P/tB 4.59
EV/EBITDA N/A
EPS(TTM)-1.9
EYN/A
EPS(NY)-2.47
Fwd EYN/A
FCF(TTM)-1.45
FCFYN/A
OCF(TTM)-1.15
OCFYN/A
SpS1.63
BVpS3.91
TBVpS3.91
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -21.82%
ROE -41.08%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.53%
FCFM N/A
ROA(3y)-30.14%
ROA(5y)-37.73%
ROE(3y)-99.31%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-29.33%
GM growth 5Y-26.97%
F-Score4
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 246.71%
Cap/Sales 18.42%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.65
Quick Ratio 2.48
Altman-Z N/A
F-Score4
WACC8.59%
ROIC/WACCN/A
Cap/Depr(3y)321.06%
Cap/Depr(5y)217.42%
Cap/Sales(3y)22.58%
Cap/Sales(5y)14.8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.51%
EPS Next Y28.9%
EPS Next 2Y9.39%
EPS Next 3Y8.34%
EPS Next 5Y17.21%
Revenue 1Y (TTM)6.15%
Revenue growth 3Y-5.23%
Revenue growth 5Y-8.65%
Sales Q2Q%24.66%
Revenue Next Year5.29%
Revenue Next 2Y14.07%
Revenue Next 3Y18.05%
Revenue Next 5Y42.1%
EBIT growth 1Y-37.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-11.07%
EBIT Next 3Y-23.24%
EBIT Next 5YN/A
FCF growth 1Y-80.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-151.78%
OCF growth 3YN/A
OCF growth 5YN/A

MEDIWOUND LTD / MDWD FAQ

What is the fundamental rating for MDWD stock?

ChartMill assigns a fundamental rating of 2 / 10 to MDWD.


What is the valuation status for MDWD stock?

ChartMill assigns a valuation rating of 0 / 10 to MEDIWOUND LTD (MDWD). This can be considered as Overvalued.


What is the profitability of MDWD stock?

MEDIWOUND LTD (MDWD) has a profitability rating of 1 / 10.